Minimal risk of HBV reactivation in resolved HBV-infected patients during immunosuppressive therapy

(1) Çukurova University,Adana,Turkey

(2) Çukurova University, School of Medicine,Adana,Turkey



This item was part of the Liver and Biliary III (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019